Results 61 to 70 of about 208,605 (265)

Epidémiologie et recherche sur la tuberculose au Mali: Etat des lieux

Revue Malienne d’Infectiologie et de Microbiologie, 2015
La tuberculose reste un problème de santé publique au Mali malgré les bons scores enregistrés ces dernières années aussi bien dans la lutte que dans la recherche contre la maladie.
Seydou Diabaté, Bocar Baya, Moumine Sanogo, Bassirou Diarra, Yacouba Toloba, Gaoussou Berthé, et.al.   +6 more
doaj  

Triglyceride–glucose index and FIB-4 score in relation to cardiovascular disease risk among people with HIV: a retrospective cohort study

Frontiers in Medicine
BackgroundPeople with HIV (PWH) have a high risk of cardiovascular events (CVEs). We investigated the incidence of CVEs in PWH and the usefulness of combining hepatic steatosis/insulin resistance (HS-IR) and risk of liver fibrosis for the evaluation of ...
María Luisa Montes, María Luisa Montes, Carmen Busca, Carmen Busca, Juan Martín-Torres, José Ignacio Bernardino, José Ignacio Bernardino, Francisco Arnaiz de las Revillas, Luz Martín-Carbonero, Luz Martín-Carbonero, Jorge Sánchez Villegas, Rafael Micán, Rafael Micán, David Dalmau, Maria Mar Arcos, María de la Villa López Sánchez, Alejandro de Gea, Sofía Ibarra Ugarte, José Ramón Arribas, José Ramón Arribas, Juan González-García, Juan González-García   +21 more
doaj   +1 more source

Facteurs influençant la perte de vue et la mortalité chez les personnes vivant avec le VIH suivies au Centre de Traitement Ambulatoire de Koula-Moutou (Gabon) de 2005 à 2015

The Pan African Medical Journal, 2016
INTRODUCTION: cette étude avait pour but principal d'évaluer les facteurs biologiques et cliniques associés aux pertes de vue et à la mortalité des patients suivis au Centre de Traitement Ambulatoire VIH/SIDA (CTA) de Koula-Moutou.
Arnaud Mongo-Delis, Patrick Mickala, Landry Erik Mombo, Wilfried Schobert Bouedy, Jean-Charles Etho Mengue, Guy-Landry Itsonoganga, Léonce Parfait Alompie, Gerda Bitombo, Cyrille Bisseye   +8 more
doaj   +1 more source

Phosphorylation of the Arginine-Rich C-Terminal Domains of the Hepatitis B Virus (HBV) Core Protein as a Fine Regulator of the Interaction between HBc and Nucleic Acid

Viruses, 2020
The morphogenesis of Hepatitis B Virus (HBV) viral particles is nucleated by the oligomerization of HBc protein molecules, resulting in the formation of an icosahedral capsid shell containing the replication-competent nucleoprotein complex made of the ...
Hugues de Rocquigny, Virgile Rat, Florentin Pastor, Jean Luc Darlix, Christophe Hourioux, Philippe Roingeard   +5 more
doaj   +1 more source

Impact of Human Immunodeficiency Virus Infection on the Outcome of Treatment and Survival of Tuberculosis Patients in Mwanza, Tanzania. [PDF]

, 1998
Little is known about the outcome of tuberculosis (TB) treatment and subsequent survival of human immunodeficiency virus (HIV) infected patients treated under routine programme conditions in a developing country.
Lefi, M, Mfinanga, S, Moshiro, C, Mugomela, A, O'Brien, R, van den Broek, J   +5 more
core  

Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya [PDF]

, 2010
SETTING: In July 2005, Médecins Sans Frontières and the Ministry of Health, Kenya, implemented an integrated tuberculosis-human immunodeficiency virus (TB-HIV) programme in western Kenya.
Guerrero, W, Huerga, H, Odongo, A, Spillane, H, Varaine, F   +4 more
core   +1 more source

Effective and safe use of immune checkpoint inhibitors for non‐small cell lung cancer in people living with HIV

HIV Medicine, Volume 26, Issue 12, Page 1909-1919, December 2025.
Abstract Objectives With the near normalization of life expectancy in people living with HIV through antiretroviral therapy, the management of age‐related comorbidities has become increasingly important. Non‐AIDS‐defining cancers now contribute significantly to both morbidity and mortality in this population, with non‐small cell lung cancer (NSCLC ...
Rebekka Mispelbaum, Tessa Hattenhauer, Christian Hoffmann, Clara Lehmann, Franz‐Georg Bauernfeind, Peter Brossart, Maximilian Christopeit, Winfried Alsdorf, Carsten Bokemeyer, Julian P. Layer, Julia Roider, Marcus Hentrich, Malte Benedikt Monin   +12 more
wiley   +1 more source

El reto del envejecimiento y la complejidad farmacoterapéutica en el paciente VIH+ [PDF]

, 2018
Objective: To describe the current knowledge and management of aging and pharmacotherapeutic complexity in HIV + patients. Method: A review of literature was carried out, including articles, originals or reviews, published in English or Spanish, from ...
Abdel Kader Martín, Laila, Morillo Verdugo, Ramón A., Ramos Blanco, José Ramón, Álvarez de Sotomayor Paz, María   +3 more
core   +3 more sources

NUDIX hydrolases target specific inositol pyrophosphates and regulate phosphate homeostasis and bacterial pathogen susceptibility in Arabidopsis

Journal of Integrative Plant Biology, Volume 67, Issue 12, Page 3123-3151, December 2025.
NUDIX‐type hydrolase enzymes of subclade I and II preferentially target the inositol pyrophosphate messengers 4‐ and 3‐InsP7, respectively. Inactivation of subclade II NUDTs disrupts phosphate homeostasis and enhances bacterial resistance, revealing connections between defense and nutrient signaling.
Robin Schneider, Klea Lami, Isabel Prucker, Sara Christina Stolze, Annett Strauß, Julie Marie Schmidt, Simon M. Bartsch, Kevin Langenbach, Esther Lange, Kevin Ritter, David Furkert, Natalie Faiß, Sandeep Kumar, M. Shamim Hasan, Athanasios Makris, Lukas Krusenbaum, Stefanie Wege, Yemisrach Zewdu Belay, Simon Kriescher, Jeremy The, Michael Harings, Florian M. W. Grundler, Martina K. Ried‐Lasi, Heiko Schoof, Philipp Gaugler, Marília Kamleitner, Dorothea Fiedler, Hirofumi Nakagami, Ricardo F. H. Giehl, Thomas Lahaye, Saikat Bhattacharjee, Henning J. Jessen, Verena Gaugler, Gabriel Schaaf   +33 more
wiley   +1 more source

HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon

BMC Infectious Diseases
Introduction In 2022, the WHO reported that 29.8 million people around the world were living with HIV (PLHIV) and receiving antiretroviral treatment (ART), including 25‌ 375 people in Gabon (54% of all those living with HIV in the country).
Guy Francis Nzengui-Nzengui, Gaël Mourembou, Hervé M’boyis-Kamdem, Ayawa Claudine Kombila-Koumavor, Angélique Ndjoyi-Mbiguino   +4 more
doaj   +1 more source